Clinical Characteristics and Prognostic Factors of Lung Cancer in Korea: A Pilot Study of Data from the Korean Nationwide Lung Cancer Registry
Ho Cheol Kim, Chi Young Jung, Deog Gon Cho, Jae Hyun Jeon, Jeong Eun Lee, Jin Seok Ahn, Seung Joon Kim, Yeongdae Kim, Young-Chul Kim, Jung-Eun Kim, Boram Lee, Young-Joo Won, Chang-Min Choi
Tuberc Respir Dis. 2019;82(2):118-125.   Published online 2018 Jun 19     DOI: https://doi.org/10.4046/trd.2017.0128
Citations to this article as recorded by Crossref logo
Difference of copy number variation in blood of patients with lung cancer
Yeonjeong Heo, Jeongwon Heo, Seon-sook Han, Woo Jin Kim, Hyun Sub Cheong, Yoonki Hong
The International Journal of Biological Markers.2021; 36(1): 3.     CrossRef
Biomarkers and diagnostic tools for lung cancer
Sang Hoon Lee, Eun Hye Lee, Eun Young Kim, Yong Jun Choi, Yoon Jin Cha, Yoon Soo Chang
Journal of the Korean Medical Association.2021; 64(1): 66.     CrossRef
Treatment outcomes and safety of afatinib in advanced squamous cell lung cancer progressed after platinum‐based doublet chemotherapy and immunotherapy ( SPACE study)
Seung Hyeun Lee, Cheol‐Kyu Park, Sung Yong Lee, Chang‐Min Choi
Thoracic Cancer.2021; 12(8): 1264.     CrossRef
Long-term progression-free survival in a patient with advanced non-small-cell lung cancer treated with low-dose gefitinib and traditional herbal medicine
Beom-Joon Lee, Kwan-Il Kim, Cheong-Woon Choi, Jong Yeol Kim, Jun-Hwan Lee
Medicine.2021; 100(5): e24292.     CrossRef
Update on pharmacotherapy for smoking cessation
Hye Sook Choi, Jae Yeol Kim
Journal of the Korean Medical Association.2021; 64(3): 216.     CrossRef
Recent Trends of Lung Cancer in Korea
Jae Guk Lee, Ho Cheol Kim, Chang-Min Choi
Tuberculosis and Respiratory Diseases.2021; 84(2): 89.     CrossRef
Awareness and Use of Complementary and Alternative Medicine in Korean Lung Cancer Patients
Joon Young Choi, Wonjun Ji, Chang-Min Choi, Chaeuk Chung, Jae Myoung Noh, Cheol-Kyu Park, In-Jae Oh, Hong In Yoon, Hyeong Ryul Kim, Ho Young Kim, Chang Dong Yeo, Seung Hun Jang
Tuberculosis and Respiratory Diseases.2021; 84(2): 105.     CrossRef
Identification of 4 immune cells and a 5-lncRNA risk signature with prognosis for early-stage lung adenocarcinoma
Lan Mu, Ke Ding, Ranran Tu, Wei Yang
Journal of Translational Medicine.2021;[Epub]     CrossRef
Air Pollution and Incidence of Lung Cancer by Histological Type in Korean Adults: A Korean National Health Insurance Service Health Examinee Cohort Study
Da Hye Moon, Sung Ok Kwon, Sun-Young Kim, Woo Jin Kim
International Journal of Environmental Research and Public Health.2020; 17(3): 915.     CrossRef
Current Status of Immunotherapy for Lung Cancer and Future Perspectives
Ho Cheol Kim, Chang-Min Choi
Tuberculosis and Respiratory Diseases.2020; 83(1): 14.     CrossRef
Efficacy of immune checkpoint inhibitors according to PD‐L1 tumor proportion scores in non‐small cell lung cancer
Seongho Park, Yoo‐Duk Choi, Jieun Kim, Bo‐Gun Kho, Cheol‐Kyu Park, In‐Jae Oh, Young‐Chul Kim
Thoracic Cancer.2020; 11(2): 408.     CrossRef
Profiles of Immune Infiltration and Prognostic Immunoscore in Lung Adenocarcinoma
Yanyan Li, Liping Tao, Weiyang Cai
BioMed Research International.2020; 2020: 1.     CrossRef

Diagnostic and Predictive Values of 18F-FDG PET/CT Metabolic Parameters in EGFR-Mutated Advanced Lung Adenocarcinoma

Il Ki Hong, Jeong Mi Lee, In Kyoung Hwang, Seung Sook Paik, Chanwoo Kim, Seung Hyeun Lee
Cancer Management and Research.2020; Volume 12: 6453.     CrossRef

High PD-L1 Expression is Associated with Unfavorable Clinical Outcome in EGFR-Mutated Lung Adenocarcinomas Treated with Targeted Therapy

Byung Woo Yoon, Boksoon Chang, Seung Hyeun Lee
OncoTargets and Therapy.2020; Volume 13: 8273.     CrossRef

Reactive Oxygen Species Modulator 1 is Associated with Poor Survival in Patients with Non-Small Cell Lung Cancer After Stereotactic Fractionated Radiosurgery: A Retrospective Pilot Study

Moonkyoo Kong, Ji-Youn Sung, Seung Hyeun Lee
OncoTargets and Therapy.2020; Volume 13: 8173.     CrossRef
miR-196b-5p Promotes Proliferation, Migration and Invasion of Lung Adenocarcinoma Cells via Targeting RSPO2
Qian Xu, Zhenwu Xu
Cancer Management and Research.2020; Volume 12: 13393.     CrossRef
Reactive oxygen species modulator 1 expression predicts lymph node metastasis and survival in early-stage non-small cell lung cancer
Taehee Kim, Yoon Jin Cha, Ji Hyun Park, Arum Kim, Yong Jun Choi, Hye Jung Park, Jung Weon Lee
PLOS ONE.2020; 15(12): e0239670.     CrossRef
Effect of medical thoracoscopy‐guided intrapleural docetaxel therapy to manage malignant pleural effusion in patients with non‐small cell lung cancer: A pilot study
Myeong Geun Choi, Sojung Park, Dong Kyu Oh, Hyeong Ryul Kim, Geun Dong Lee, Jae Cheol Lee, Chang‐Min Choi, Wonjun Ji
Thoracic Cancer.2019; 10(10): 1885.     CrossRef
Epigenome-Wide Association Analysis of Differentially Methylated Signals in Blood Samples of Patients with Non-Small-Cell Lung Cancer
Yoonki Hong, Hye-Mi Choi, Hyun Sub Cheong, Hyoung Doo Shin, Chang Min Choi, Woo Jin Kim
Journal of Clinical Medicine.2019; 8(9): 1307.     CrossRef
Report of the Korean Association of Lung Cancer Registry (KALC-R), 2014
Chang-Min Choi, Ho Cheol Kim, Chi Young Jung, Deog Gon Cho, Jae Hyun Jeon, Jeong Eun Lee, Jin Seok Ahn, Seung Joon Kim, Yeongdae Kim, Yoo-Duk Choi, Yang-Gun Suh, Jung-Eun Kim, Boram Lee, Young-Joo Won, Young-Chul Kim
Cancer Research and Treatment.2019; 51(4): 1400.     CrossRef
Trends and Updated Statistics of Lung Cancer in Korea
Chan Kwon Park, Seung Joon Kim
Tuberculosis and Respiratory Diseases.2019; 82(2): 175.     CrossRef
MicroRNA-374a Expression as a Prognostic Biomarker in Lung Adenocarcinoma
Yeseul Kim, Jongmin Sim, Hyunsung Kim, Seong Sik Bang, Seungyun Jee, Sungeon Park, Kiseok Jang
Journal of Pathology and Translational Medicine.2019; 53(6): 354.     CrossRef